TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts ...

Supply from drugmakers for the stimulant medications most commonly prescribed for ADHD are still falling short of demand, the Food and Drug Administration says, and many Americans who rely on these ...

India's first private drug quality audit finds generics match branded medicines for safety and efficacy—at a fraction of the ...

The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap ...

Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

The post The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did appeared first on ProPublica.

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...

Generic drugs can save you money, but some could also make you very sick. A new Ohio State University study found that manufacturing differences between the U.S. and other countries, mainly India, can ...

Billionaire investor and businessman Mark Cuban recently met with leaders at Penn Medicine, including University of Pennsylvania Health System CEO Kevin Mahoney (left) and Penn Medicine vice president ...